292 related articles for article (PubMed ID: 34802772)
1. Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.
Chua KP; Dahlem CHY; Nguyen TD; Brummett CM; Conti RM; Bohnert AS; Dora-Laskey AD; Kocher KE
Ann Emerg Med; 2022 Mar; 79(3):225-236. PubMed ID: 34802772
[TBL] [Abstract][Full Text] [Related]
2. Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis.
Hartmann RJ; Elder JD; Terrett LA
CMAJ Open; 2021; 9(1):E79-E86. PubMed ID: 33514601
[TBL] [Abstract][Full Text] [Related]
3. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
4. Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiation.
Sun T; Aroke H; Kogut S; Katenka N; Bratberg J; Buchanan A
Am J Drug Alcohol Abuse; 2022 Mar; 48(2):217-225. PubMed ID: 34780312
[No Abstract] [Full Text] [Related]
5. Naloxone Administration in US Emergency Departments, 2000-2011.
Frank JW; Levy C; Calcaterra SL; Hoppe JA; Binswanger IA
J Med Toxicol; 2016 Jun; 12(2):148-56. PubMed ID: 26621354
[TBL] [Abstract][Full Text] [Related]
6. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J
JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394
[TBL] [Abstract][Full Text] [Related]
7. Sustained Implementation of a Multicomponent Strategy to Increase Emergency Department-Initiated Interventions for Opioid Use Disorder.
Lowenstein M; Perrone J; Xiong RA; Snider CK; O'Donnell N; Hermann D; Rosin R; Dees J; McFadden R; Khatri U; Meisel ZF; Mitra N; Delgado MK
Ann Emerg Med; 2022 Mar; 79(3):237-248. PubMed ID: 34922776
[TBL] [Abstract][Full Text] [Related]
8. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
[TBL] [Abstract][Full Text] [Related]
9. Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.
Kilaru AS; Liu M; Gupta R; Perrone J; Delgado MK; Meisel ZF; Lowenstein M
Am J Emerg Med; 2021 Sep; 47():154-157. PubMed ID: 33812332
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
[TBL] [Abstract][Full Text] [Related]
11. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
12. Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases.
Sugarman OK; Saloner B; Richards TM; Lasser EC; Heath T; Idries S; Weiner JP; Bandara S
Drug Alcohol Depend; 2024 May; 258():111281. PubMed ID: 38599134
[TBL] [Abstract][Full Text] [Related]
13. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
Rhee TG; Rosenheck RA
Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
16. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
[TBL] [Abstract][Full Text] [Related]
17. Disparities in Emergency Department Naloxone and Buprenorphine Initiation.
Papp J; Emerman C
West J Emerg Med; 2023 Jun; 24(4):710-716. PubMed ID: 37527392
[TBL] [Abstract][Full Text] [Related]
18. Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
D'Onofrio G; Edelman EJ; Hawk KF; Chawarski MC; Pantalon MV; Owens PH; Martel SH; Rothman R; Saheed M; Schwartz RP; Cowan E; Richardson L; Salsitz E; Lyons MS; Freiermuth C; Wilder C; Whiteside L; Tsui JI; Klein JW; Coupet E; O'Connor PG; Matthews AG; Murphy SM; Huntley K; Fiellin DA
JAMA Netw Open; 2023 Apr; 6(4):e235439. PubMed ID: 37017967
[TBL] [Abstract][Full Text] [Related]
19. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose.
Follman S; Arora VM; Lyttle C; Moore PQ; Pho MT
JAMA Netw Open; 2019 May; 2(5):e193209. PubMed ID: 31050777
[TBL] [Abstract][Full Text] [Related]
20. Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment.
Samuels EA; Wentz A; McCormick M; McDonald JV; Marshall BDL; Friedman C; Koziol J; Alexander-Scott NE
Ann Emerg Med; 2021 Jul; 78(1):68-79. PubMed ID: 33865617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
